Last reviewed · How we verify

NCT03099070

Acute Stress Response in Migraine Sufferers

Terminated NA Last updated 23 August 2023
What this trial tests

NA trial testing Stress in Migraine Headache in 90 participants. Terminated before completion.

Timeline
8 March 2017
Primary endpoint
15 August 2020
15 August 2020

Quick facts

Lead sponsorMassachusetts General Hospital
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposebasic science
Enrollment90
Start date8 March 2017
Primary completion15 August 2020
Estimated completion15 August 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Massachusetts General Hospital

Who can join

Adults 18 to 65, any sex, with Migraine Headache. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will examine the influence of stress and fasting on headache activity. Participants will receive both a control and stress session and be randomized to either fasting or not fasting for the visits.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Stress

Trials testing the same drug.

Other recruiting trials for Migraine Headache

Currently open trials in the same condition.

Other Massachusetts General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03099070.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing